These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Peskind ER; Potkin SG; Pomara N; Ott BR; Graham SM; Olin JT; McDonald S Am J Geriatr Psychiatry; 2006 Aug; 14(8):704-15. PubMed ID: 16861375 [TBL] [Abstract][Full Text] [Related]
7. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I; JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594 [TBL] [Abstract][Full Text] [Related]
8. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT; Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936 [TBL] [Abstract][Full Text] [Related]
9. Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Winblad B; Poritis N Int J Geriatr Psychiatry; 1999 Feb; 14(2):135-46. PubMed ID: 10885864 [TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. Guekht AB; Moessler H; Novak PH; Gusev EI; J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516 [TBL] [Abstract][Full Text] [Related]
16. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967 [TBL] [Abstract][Full Text] [Related]
17. [Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia]. Gavrilova SI; Kolykhalov IV; Mikhaylova NM; Ponomareva EV; Fedorova YB; Medvedev VE; Frolova VI; Gushanskaya EV; Litvinenko IV; Emelin AY; Lobzin VY; Kashin AV; Tanashyan MM; Kachanova MV; Knyazev AV; Gonik MI Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):69-77. PubMed ID: 38465812 [TBL] [Abstract][Full Text] [Related]